Czech Centre for Phenogenomics tested 2nd-generation double antibody developed by Institute for Research in Biomedicine

  • published: 26. 1. 2021

The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation ‘double antibody’ that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy.

Source: BIOCEV

More information – www.biocev.eu.
Publication – www.biorxiv.org.